UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral Anticoagulant Use after Bariatric Surgery: A Literature Review and Clinical Guidance

The American journal of medicine, 2017-05, Vol.130 (5), p.517-524

2017

Volltextzugriff (PDF)

Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018

Journal of the American Heart Association, 2020-09, Vol.9 (17), p.e016784-e016784

2020

Volltextzugriff (PDF)

Preventing venous thromboembolism for ambulatory patients with cancer: Developing the form and content of implementation strategies

Thrombosis update, 2024-06, Vol.15, p.100168, Article 100168

2024

Volltextzugriff (PDF)

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.1874-1882

2021

Volltextzugriff (PDF)

Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis

Research and practice in thrombosis and haemostasis, 2020-10, Vol.4 (7), p.1211-1215

2020

Volltextzugriff (PDF)

Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment

Journal of clinical medicine, 2023-12, Vol.13 (1), p.96

2023

Volltextzugriff (PDF)

Anticoagulation practice patterns in COVID‐19: A global survey

Research and practice in thrombosis and haemostasis, 2020-08, Vol.4 (6), p.969-983

2020

Volltextzugriff (PDF)

Venous Thromboembolism and Obesity: Moving Toward a Better Understanding of the Population-Attributable Risk

Thrombosis and haemostasis, 2024-03, Vol.124 (3), p.250-252

2024

Volltextzugriff (PDF)

Words Matter: a Call to Remove "Sickler" from Medical Lingo in the United States

Journal of general internal medicine : JGIM, 2024-09

2024

Volltextzugriff (PDF)

A safe and effective use of caplacizumab in pregnancy‐related acquired thrombotic thrombocytopenic purpura

British journal of haematology, 2023-08, Vol.202 (4), p.879-882

2023

Volltextzugriff (PDF)

Racial Disparities Exist Across Age Groups in Illinois for Pulmonary Embolism Hospitalizations

Arteriosclerosis, thrombosis, and vascular biology, 2020-09, Vol.40 (9), p.2338-2340

2020

Volltextzugriff (PDF)

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment

Research and practice in thrombosis and haemostasis, 2022-05, Vol.6 (4), p.e12740-n/a, Article e12740

2022

Volltextzugriff (PDF)

Barriers and facilitators to preventing venous thromboembolism in oncology practice

Thrombosis research, 2022-12, Vol.220, p.21-23

2022

Volltextzugriff (PDF)

Chronic thromboembolic pulmonary hypertension: anticoagulation and beyond

Hematology, 2021-12, Vol.2021 (1), p.478-484

2021

Volltextzugriff (PDF)

Improving Judicious Use of Heparin-Induced Thrombocytopenia Testing Through Electronic Health Record–Based Intervention

Joint Commission journal on quality and patient safety, 2023-11, Vol.49 (11), p.648-654

2023

Volltextzugriff (PDF)

Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report

American journal of transplantation, 2023-03, Vol.23 (3), p.437-439

2023

Volltextzugriff (PDF)

Anticoagulant drug choice in patients who have had bariatric surgery – Presently, DOACs are not the preferred choice

Thrombosis research, 2018-03, Vol.163, p.196-199

2018

Volltextzugriff (PDF)

Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 Infection

JAMA oncology, 2021-07, Vol.7 (7), p.1065

2021

Volltextzugriff (PDF)

DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network

Journal of thrombosis and thrombolysis, 2023-05, Vol.55 (4), p.685-690

2023

Volltextzugriff (PDF)

DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network

Thrombosis research, 2023-09, Vol.229, p.146-148

2023

Volltextzugriff (PDF)

Rural-urban differences in pulmonary embolism mortality by race-ethnicity and sex in the United States, 1999–2020

Journal of thrombosis and thrombolysis, 2024-02, Vol.57 (2), p.337-340

2024

Volltextzugriff (PDF)

When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2024-01, Vol.83 (3), p.444

2024

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome: Findings From a Phase 1a Trial

American journal of kidney diseases, 2023-03, Vol.81 (3), p.373-376

2023

Volltextzugriff (PDF)

Pulmonary embolism–related mortality during the COVID‐19 pandemic: Data from the United States

Research and practice in thrombosis and haemostasis, 2022-11, Vol.6 (8), p.e12845-n/a, Article e12845

2022

Volltextzugriff (PDF)

Long-term antithrombotic therapy after venous stent placement

Phlebology, 2020-07, Vol.35 (6), p.402-408

2020

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Oral Anticoagulant Use after Bariatric Surgery: A Literature Review and Clinical Guidance

Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018

Preventing venous thromboembolism for ambulatory patients with cancer: Developing the form and content of implementation strategies

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis

Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment

Anticoagulation practice patterns in COVID‐19: A global survey

Venous Thromboembolism and Obesity: Moving Toward a Better Understanding of the Population-Attributable Risk

Words Matter: a Call to Remove "Sickler" from Medical Lingo in the United States

A safe and effective use of caplacizumab in pregnancy‐related acquired thrombotic thrombocytopenic purpura

Racial Disparities Exist Across Age Groups in Illinois for Pulmonary Embolism Hospitalizations

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment

Barriers and facilitators to preventing venous thromboembolism in oncology practice

Chronic thromboembolic pulmonary hypertension: anticoagulation and beyond

Improving Judicious Use of Heparin-Induced Thrombocytopenia Testing Through Electronic Health Record–Based Intervention

Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report

Anticoagulant drug choice in patients who have had bariatric surgery – Presently, DOACs are not the preferred choice

Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 Infection

DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network

DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network

Rural-urban differences in pulmonary embolism mortality by race-ethnicity and sex in the United States, 1999–2020

When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome: Findings From a Phase 1a Trial

Pulmonary embolism–related mortality during the COVID‐19 pandemic: Data from the United States

Long-term antithrombotic therapy after venous stent placement

Suchergebnisse filtern